Medicines360: Creating Equitable Access

Nov 11, 2022



by Tina Raine-Bennett

Our Mission is to catalyze equitable access to medicines and devices through product development, policy advocacy, and collaboration with global and U.S. partners

We are expanding access to our IUD in Africa, South and Southeast Asia, Central America, and the Caribbean, under the brand AvibelaTM

AVIBELA is manufactured in Belgium and supplied to global and local partners by Medicines360

Local partners lead distribution, training, and service delivery
AVIBELA is available at a subsidized access price for all units ordered through international procurement group catalogs or on behalf of eligible public sector programs.

For questions or to learn more about Avibela and about the new products and partnerships in our pipeline, visit,, or email


Learn more about the Medicines360:

The ICFP2022 Recap Report is out now

The ICFP2022 Recap Report is out now

Unlocking the Latest Research, Innovations, and Collaborations The International Conference on Family Planning (ICFP) has just announced the launch of the official ICFP2022 Recap Report. The report provides a comprehensive summary of all the major highlights from the...

Will the world abort women’s rights after death of Roe v Wade?

Will the world abort women’s rights after death of Roe v Wade?

Originally posted by Reuters“You have heard the term that when the U.S. sneezes, the rest of the world catches a cold,” said Jade Maina, executive director of Trust for Indigenous Culture and Health, a health advocacy group based in Nairobi. “This is what we are...